IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lindenberg, Jelle J ^a   Oosterhoff, Dinja ^a   Sombroek, Claudia C ^a   Lougheed, Sinéad M ^a   Hooijberg, Erik ^a   Stam, Anita G M ^a   Santegoets, Saskia J A M ^a   Tijssen, Henk J ^b   Buter, Jan ^a   Pinedo, Herbert M ^a   van den Eertwegh, Alfons J M ^a   Scheper, Rik J ^a   Koenen, Hans J P M ^b   van de Ven, Rieneke ^a   de Gruijl, Tanja D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD209 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERLEUKIN 10; INTERLEUKIN 12P70; MELAN A; PROGRAMMED DEATH 1 LIGAND 1; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BREAST TUMOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL GROWTH; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DERMIS; EXPLANT; HUMAN; HUMAN TISSUE; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION;

ANALYSIS OF VARIANCE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIFFERENTIATION; CELL MOVEMENT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; LANGERHANS CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 84880446912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070237     Document Type: Article

References (52)

1. Palucka K, Banchereau J, (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12: 265-277.
2. Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system.
3. Oosterhoff D, Sluijter BJ, Hangalapura BN, de Gruijl TD, (2012) The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma. Curr Top Microbiol Immunol 351: 181-220.
4. Nestle FO, Di MP, Qin JZ, Nickoloff BJ, (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9: 679-691.
5. Molenkamp BG, Vuylsteke RJ, van Leeuwen PA, Meijer S, Vos W, et al. (2005) Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells. Am J Pathol 167: 1301-1307.
6. Ueno H, Klechevsky E, Schmitt N, Ni L, Flamar AL, et al. (2011) Targeting human dendritic cell subsets for improved vaccines. Semin Immunol 23: 21-27.
7. Peiser M, Wanner R, Kolde G, (2004) Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. J Leukoc Biol 76: 616-622.
8. Banchereau J, Thompson-Snipes L, Zurawski S, Blanck JP, Cao Y, et al. (2012) The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood 1195742-5749blood-2011-08-371245.
9. Ratzinger G, Baggers J, de Cos MA, Yuan J, Dao T, et al. (2004) Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 173: 2780-2791.
10. van der Aar AM, de Groot R, Sanchez-Hernandez M, Taanman EW, van Lier RA, et al. (2011) Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses. J Immunol 187: 3488-3492.
11. Furio L, Briotet I, Journeaux A, Billard H, Peguet-Navarro J, (2010) Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells. J Invest Dermatol 130: 1345-1354.
12. de Jong A, Pena-Cruz V, Cheng TY, Clark RA, Van Rhijn I, et al. (2010) CD1a-autoreactive T cells are a normal component of the human alphabeta T cell repertoire. Nat Immunol 11: 1102-1109.
13. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, et al. (2009) Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A 106: 21795-21800.
14. Morelli AE, Rubin JP, Erdos G, Tkacheva OA, Mathers AR, et al. (2005) CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J Immunol 175: 7905-7915.
15. Mathers AR, Janelsins BM, Rubin JP, Tkacheva OA, Shufesky WJ, et al. (2009) Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol 182: 921-933.
16. Mathers AR, Larregina AT, (2006) Professional antigen-presenting cells of the skin. Immunol Res 36: 127-136 IR:36:1:127.
17. Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS, (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36: 873-884.
18. Chu CC, Ali N, Karagiannis P, Di MP, Skowera A, et al. (2012) Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 209: 935-945.
19. de Gruijl TD, Sombroek CC, Lougheed SM, Oosterhoff D, Buter J, et al. (2006) A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J Immunol 176: 7232-7242.
20. Pinedo HM, Buter J, Luykx-de Bakker SA, Pohlmann PR, van Hensbergen Y, et al. (2003) Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer 39: 1061-1067.
21. Honkoop AH, Luykx-de Bakker SA, Hoekman K, Meyer S, Meyer OW, et al. (1999) Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer. Oncologist 4: 106-111.
22. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC, (1998) Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161: 5245-5251.
23. Sombroek CC, Stam AG, Masterson AJ, Lougheed SM, Schakel MJ, et al. (2002) Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 168: 4333-4343.
24. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, et al. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352 blood-2008-01-133967.
25. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
26. Santegoets SJ, Bontkes HJ, Stam AG, Bhoelan F, Ruizendaal JJ, et al. (2008) Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model. J Immunol 180: 4540-4549.
27. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, et al. (2010) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207: 1247-1260.
28. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, et al. (2012) Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37: 60-73 S1074-7613(12)00279-8.
29. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
30. Kaplan DH, Kissenpfennig A, Clausen BE, (2008) Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 38: 2369-2376.
31. Romani N, Flacher V, Tripp CH, Sparber F, Ebner S, et al. (2012) Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol 351: 113-138.
32. Teunissen MB, Haniffa M, Collin MP, (2012) Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol 351: 25-76.
33. Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, et al. (2002) DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 168: 2634-2643.
34. Banchereau J, Zurawski S, Thompson-Snipes L, Blanck JP, Clayton S, et al. (2012) Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A 109: 18885-18890.
35. Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA, (2007) Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 117: 2517-2525.
36. Haniffa M, Ginhoux F, Wang XN, Bigley V, Abel M, et al. (2009) Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 206: 371-385.
37. Ouwehand K, Oosterhoff D, Breetveld M, Scheper RJ, de Gruijl TD, et al. (2011) Irritant-induced migration of Langerhans cells coincides with an IL-10-dependent switch to a macrophage-like phenotype. J Invest Dermatol 131: 418-425.
38. Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, et al. (2001) Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2: 1151-1158.
39. Dominguez-Soto A, Sierra-Filardi E, Puig-Kroger A, Perez-Maceda B, Gomez-Aguado F, et al. (2011) Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J Immunol 186: 2192-2200.
40. Velten FW, Duperrier K, Bohlender J, Metharom P, Goerdt S, (2004) A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur J Immunol 34: 2800-2811.
41. Ramanathapuram LV, Hopkin D, Kurago ZB (2011) Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16(+) DC Phenotype and Control DC Migration. Cancer Microenviron.
42. Wilson AJ, Maddox PH, Jenkins D, (1991) CD1a and S100 antigen expression in skin Langerhans cells in patients with breast cancer. J Pathol 163: 25-30.
43. Nolan KF, Strong V, Soler D, Fairchild PJ, Cobbold SP, et al. (2004) IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J Immunol 172: 2201-2209.
44. Takayama T, Morelli AE, Onai N, Hirao M, Matsushima K, et al. (2001) Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol 166: 7136-7143.
45. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, et al. (2008) Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29: 497-510.
46. Santegoets SJ, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, et al. (2008) Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol 84: 143-151.
47. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, et al. (1996) IL-12 synthesis by human Langerhans cells. J Immunol 156: 1402-1407.
48. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F, (2000) Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 1: 311-316.
49. Camporeale A, Boni A, Iezzi G, Degl'Innocenti E, Grioni M, et al. (2003) Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res 63: 3688-3694.
50. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA, (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483.
51. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3: 1135-1141.
52. Sonnenberg GF, Fouser LA, Artis D, (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-390.